You have 9 free searches left this month | for more free features.

Personalized Risk Factors

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Drammen (Polygenetic risk score)

Recruiting
  • Breast Cancer
  • Polygenetic risk score
  • Drammen, Norway
    Vestre Viken Hospital Trust
Feb 16, 2023

Acute Kidney Injury Trial (Risk-guided transition of care intervention delivered through an integrated digital health strategy)

Not yet recruiting
  • Acute Kidney Injury
  • Risk-guided transition of care intervention delivered through an integrated digital health strategy
  • (no location specified)
Apr 6, 2023

Next-generation, Integrative, and Personalized Risk Assessment

Recruiting
  • Heart Failure
  • Comprehensive risk assessment algorithm
  • L'Hospitalet de Llobregat, Barcelona, Spain
    University Hospital Bellvitge
Jan 8, 2023

IBD, Crohn Disease, Crohn Colitis Trial in Boston (Personalized Risk Estimation for Crohn's Disease (PRE-CD) tool, Standard

Not yet recruiting
  • Inflammatory Bowel Diseases
  • +7 more
  • Personalized Risk Estimation for Crohn's Disease (PRE-CD) tool
  • Standard Crohn's Disease Education
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 11, 2022

Personalized Risk of Rapidly Progressive Atherosclerosis

Completed
  • Atherosclerosis, Coronary
  • without Intervention
  • Novosibirsk, Novosibirskaja Oblast' (oblast'), Russian Federation
    Novosibirsk State Medical University
Aug 4, 2022

Diabetic Complication Trial in Shatin (Personalized Risk Counselling, Normal usual care)

Completed
  • Diabetic Complication
  • Personalized Risk Counselling
  • Normal usual care
  • Shatin, Hong Kong
    Prince of Wales Hospital
Mar 6, 2022

Cognitive Impairment, Stroke, Dementia Trial in Hangzhou (Personalized multidomain intervention)

Not yet recruiting
  • Cognitive Impairment
  • +2 more
  • Personalized multidomain intervention
  • Hangzhou, Zhejiang, China
    Min Lou
Jun 25, 2023

Cardiac Output, Surgery, Postoperative Complications Trial (Personalized hemodynamic management)

Not yet recruiting
  • Cardiac Output
  • +3 more
  • Personalized hemodynamic management
  • (no location specified)
Dec 28, 2022

Breast Tumors Trial in Padova (Personalized screening protocol)

Active, not recruiting
  • Breast Neoplasms
  • Personalized screening protocol
  • Padova, Italy
    Istituto Oncologico Veneto (IRCCS)
Dec 21, 2022

Breast Cancer, Breast Cancer Female, Survivorship Trial in Netherlands (personalized surveillance plans (PSP) and personalized

Enrolling by invitation
  • Breast Cancer
  • +2 more
  • personalized surveillance plans (PSP) and personalized aftercare plans (PAP)
  • Den Bosch, Brabant, Netherlands
  • +9 more
Aug 2, 2023

Macular Degeneration Trial in Bordeaux (MacuTest platform)

Not yet recruiting
  • Macular Degeneration
  • MacuTest platform
  • Bordeaux, France
    CHU Bordeaux
Dec 28, 2022

Diet, Healthy, High Risk Trial (Mediteranean to Western to Mediteranean Diet, Western to Mediteranean to Western Diet)

Not yet recruiting
  • Diet, Healthy
  • High Risk
  • Mediteranean to Western to Mediteranean Diet
  • Western to Mediteranean to Western Diet
  • (no location specified)
Oct 17, 2022

Breast Screening Trial in Worldwide (Mammogram, Ultrasound, MRI)

Recruiting
  • Breast Screening
  • Mammogram
  • +3 more
  • Bruxelles, Belgium
  • +5 more
Apr 13, 2022

Sarcopenia Trial in Nijmegen (FITFOOD lifestyle intervention)

Recruiting
  • Sarcopenia
  • FITFOOD lifestyle intervention
  • Nijmegen, Gelderland, Netherlands
    Sabien van Exter
Oct 2, 2022

Breast Cancer Trial in Gentofte (Risk stratified arm, Control arm)

Recruiting
  • Breast Cancer
  • Risk stratified arm
  • Control arm
  • Gentofte, Denmark
    Dept. of Breast Examinations, Herlev Gentofte Hospital, Copenhag
Oct 5, 2023

Hereditary Pancreatic Cancer Trial in Oslo (Annual surveillance)

Enrolling by invitation
  • Hereditary Pancreatic Cancer
  • Annual surveillance
  • Oslo, Norway
    Oslo University Hospital
Feb 13, 2023

Diabetes, Type 2, Cardiovascular Diseases Trial in Wageningen (Personalized Dietary Advice)

Recruiting
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
  • Personalized Dietary Advice
  • Wageningen, Gelderland, Netherlands
    Wageningen University and Research
Dec 18, 2022

Blood Pressure, Intraoperative Hypotension, Postoperative Complications Trial (Personalized blood pressure management)

Not yet recruiting
  • Blood Pressure
  • +4 more
  • Personalized blood pressure management
  • (no location specified)
Nov 6, 2022

Anxiety Disorders Trial (prevANS intervention)

Not yet recruiting
  • Anxiety Disorders
  • prevANS intervention
  • (no location specified)
Jan 10, 2023

Cardiovascular Risk, Depression, Unipolar, Depression, Bipolar Trial in Assen, Groningen (LIVE)

Recruiting
  • Cardiovascular Risk
  • +2 more
  • LIVE
  • Assen, Drenthe, Netherlands
  • +1 more
Mar 1, 2023

Health-risk Behaviours, Drug Abuse Trial in Hong Kong (Health-risk behaviors, Theory of planned behavior, Self-determination

Not yet recruiting
  • Health-risk Behaviours
  • Drug Abuse
  • Health-risk behaviors
  • +5 more
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Jun 26, 2023

Hiv, HIV, Sexually Transmitted Infection Trial in Miami, Ann Arbor (Intervention LuvHub, Waitlist Control LuvHub)

Recruiting
  • Hiv
  • +5 more
  • Intervention LuvHub
  • Waitlist Control LuvHub
  • Miami, Florida
  • +1 more
Jan 23, 2023

Genetic Predisposition to Disease Trial in Paris, Cologne (BRIDGES gene panel testing, Breast cancer risk polygenic risk score

Completed
  • Genetic Predisposition to Disease
  • BRIDGES gene panel testing
  • +2 more
  • Paris, France
  • +1 more
Jan 19, 2023

Type 1 Diabetes Trial in Aurora (Home Telehealth T1D C2oYoT1-HR, Personalized Behavioral Health, Personalized Adherence

Completed
  • Type 1 Diabetes Mellitus
  • Home Telehealth T1D C2oYoT1-HR
  • +2 more
  • Aurora, Colorado
    Barbara Davis Center for Childhood Diabetes
Jul 19, 2022

Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • (no location specified)
Oct 5, 2023